As a mere shareholder they have no rights to news - just like...

As a mere shareholder they have no rights to news - just like SPL holders have encountered. etc etc
SPL can't reveal any lab work they do ( if any) . All staff and management if lab work is done should be under blackout.
ASX and ASIC are beyond useless IMO and I can't see how announcement and later webinar inform holders to a suitable level- not even close

"I like how Starpharma after having been schooled by the TGA, the MHRA , the FDA and Mundipharma "

You have it all wrong - posters here tell you that SPL has schooled all the above .